Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 1746132)

Published in Thorax on September 01, 2001

Authors

G Popescu1, M Latham, V Allgar, M W Elliott

Author Affiliations

1: Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF, UK.

Articles citing this

Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc (2008) 5.13

Impact of group education on continuous positive airway pressure adherence. J Clin Sleep Med (2013) 2.05

Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep (2009) 1.45

Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. Sleep (2013) 1.09

Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Eur Arch Otorhinolaryngol (2007) 1.01

Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med (2009) 0.99

Sleep apnea and diabetes: insights into the emerging epidemic. Curr Diab Rep (2011) 0.92

Clinical heterogeneity of patients with complex sleep apnea syndrome. Sleep Breath (2013) 0.89

Financial incentive increases CPAP acceptance in patients from low socioeconomic background. PLoS One (2012) 0.87

Assessment of the performance of nasal pillows at high CPAP pressures. J Clin Sleep Med (2013) 0.79

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP. J Thorac Dis (2016) 0.79

Pre- and in-therapy predictive score models of adult OSAS patients with poor adherence pattern on nCPAP therapy. Patient Prefer Adherence (2015) 0.78

Treatment of Obstructive Sleep Apnea in Young and Middle-Aged Adults: Effects of Positive Airway Pressure and Compliance on Arterial Stiffness, Endothelial Function, and Cardiac Hemodynamics. J Am Heart Assoc (2016) 0.77

Selective indication for positive airway pressure (PAP) in sleep-related breathing disorders with obstruction. GMS Curr Top Otorhinolaryngol Head Neck Surg (2006) 0.77

Effect of addition of chin strap on PAP compliance, nightly duration of use, and other factors. J Clin Sleep Med (2014) 0.76

Continuous positive airway pressure adherence for obstructive sleep apnea. ISRN Otolaryngol (2011) 0.75

Polysomnographic parameters during non-rapid eye movement sleep predict continuous positive airway pressure adherence. Nagoya J Med Sci (2016) 0.75

Articles cited by this

A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17

The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet (1998) 7.72

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet (1999) 6.37

Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis (1993) 5.82

The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med (1999) 5.33

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ (2000) 3.60

Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest (1997) 3.51

Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.98

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.77

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet (1994) 2.68

Night-to-night variability in CPAP use over the first three months of treatment. Sleep (1997) 2.56

Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep (1997) 2.48

Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax (1997) 2.47

Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest (1999) 2.46

The role of sleep-disordered breathing in essential hypertension. Chest (1996) 2.10

Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med (1999) 2.02

Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep (1999) 1.94

Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax (1994) 1.85

Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med (1994) 1.82

Increased mortality among sleepy snorers: a prospective population based study. Thorax (1998) 1.82

An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J (1999) 1.78

Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax (1998) 1.77

Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med (1998) 1.74

The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J (1995) 1.70

Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 1.62

Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50

Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group. CMAJ (1999) 1.37

Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest (1990) 1.36

Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest (1997) 1.24

Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. The Working Group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement à Domicile des Insuffisants Respiratoires. Chest (1997) 1.19

Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest (1994) 1.15

Long-term acceptance of continuous positive airway pressure in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.10

Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep (1996) 1.10

Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.07

Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest (1995) 1.06

Acceptance of CPAP therapy for sleep apnea. Chest (1991) 1.02

Therapeutic compliance in asthma; its magnitude and implications. Eur Respir J (1992) 1.01

A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J (1998) 0.93

Compliance with long-term oxygen therapy by concentrator. Eur Respir J (1992) 0.90

Changes in cardiac autonomic control during nocturnal repetitive oxygen desaturation episodes in patients with coronary artery disease. J Cardiovasc Risk (1996) 0.86

Compliance with LTOT and consumption of mobile oxygen. Respir Med (1999) 0.83

Articles by these authors

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet (1993) 5.43

Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet (2000) 4.05

Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax (2001) 2.83

Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33

Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax (2004) 2.07

One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax (2000) 2.04

A third way: beyond incremental reform of the Australian health economy. Aust Health Rev (1994) 2.04

Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax (1995) 2.01

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. Int J Clin Pract (2010) 1.78

Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. BMJ (2003) 1.51

Utero-ovarian blood flow characteristics of pituitary desensitization. Hum Reprod (2001) 1.42

Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis (1993) 1.41

Hypoxic challenge flight assessments in patients with severe chest wall deformity or neuromuscular disease at risk for nocturnal hypoventilation. Thorax (2009) 1.39

Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38

Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol (2005) 1.26

Excessive use of tetanus toxoid boosters. JAMA (1967) 1.25

Noninvasive ventilation for acute respiratory failure. Eur Respir J (2002) 1.18

Patellar resurfacing in primary total knee replacement: a meta-analysis. J Bone Joint Surg Am (2012) 1.18

Relationship between obstructive sleep apnoea, driving simulator performance, and risk of road traffic accidents. Thorax (2001) 1.15

Prevalence and predictors of upper airway obstruction in the first 24 hours after acute stroke. Stroke (2002) 1.15

Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet (1993) 1.11

The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod (1999) 1.10

Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child (2000) 1.10

Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J (2002) 1.08

Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome. Thorax (2004) 1.07

Randomised controlled comparison of continuous positive airways pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emerg Med J (2004) 1.03

Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol (2000) 0.98

Neuropathogenesis of simian immunodeficiency virus in neonatal rhesus macaques. Am J Pathol (1999) 0.97

Sniff esophageal and nasopharyngeal pressures and maximal relaxation rates in patients with respiratory dysfunction. Am Rev Respir Dis (1991) 0.97

Going home from hospital: the carer/patient dyad. J Adv Nurs (2001) 0.96

Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax (2003) 0.95

Rationale for the use of non-invasive ventilation in chronic ventilatory failure. Thorax (2000) 0.95

Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax (2002) 0.93

Predicting the outcome from NIV for acute exacerbations of COPD. Thorax (2000) 0.92

An analysis of the performance of UK medical graduates in the MRCOG Part 1 and Part 2 written examinations. Postgrad Med J (2012) 0.92

Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study. Autism (2009) 0.92

Sleep . 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax (2004) 0.92

Natural history of blue sclerae in osteogenesis imperfecta. Am J Med Genet (1993) 0.91

Effects of simulated obstructive sleep apnoea on the human carotid baroreceptor-vascular resistance reflex. J Physiol (2004) 0.90

Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: a new gold standard? Intensive Care Med (2002) 0.90

Daytime variability of baroreflex function in patients with obstructive sleep apnoea: implications for hypertension. Exp Physiol (2007) 0.88

Pseudotumour of the lung caused by Mycobacterium malmoense infection in an HIV positive patient. Thorax (1994) 0.88

Provision of home mechanical ventilation and sleep services for England survey. Thorax (2013) 0.87

Inspiratory muscle relaxation rate after voluntary maximal isocapnic ventilation in humans. J Appl Physiol (1985) (1991) 0.86

Chronic obstructive pulmonary disease * 9: management of ventilatory failure in COPD. Thorax (2003) 0.86

Local anaesthetic infiltration prior to arterial puncture for blood gas analysis: a survey of current practice and a randomised double blind placebo controlled trial. J R Coll Physicians Lond (1998) 0.85

Translocation of Y chromosome to an autosome in the Bolivian owl monkey, Aotus. Am J Phys Anthropol (1976) 0.85

Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009. Epidemiol Infect (2011) 0.85

Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr (2003) 0.84

Endotoxin, cytokines and lipid peroxides in children with intussusception. Br J Surg (2001) 0.83

Non-invasive ventilation in the treatment of ventilatory failure following corrective spinal surgery. Anaesthesia (2001) 0.83

Congenital anomalies in two neonatal tamarins (Saguinus oedipus and Saguinus fuscicollis). J Med Primatol (1986) 0.82

Autonomic dysfunction in patients with nocturnal hypoventilation in extrapulmonary restrictive disease. Eur Respir J (1999) 0.81

Randomised crossover study of pressure and volume non-invasive ventilation in chest wall deformity. Thorax (2005) 0.80

Energy delivery during 810 nm endovenous laser ablation of varicose veins and post-procedural morbidity. Eur J Vasc Endovasc Surg (2010) 0.80

Impact of naled on honey bee Apis mellifera L. survival and productivity: aerial ULV application using a flat-fan nozzle system. Arch Environ Contam Toxicol (2003) 0.80

Therapeutic efficacy of vitamin E and selenium in treating hemolytic anemia of owl monkeys (Aotus trivirgatus). Lab Anim Sci (1980) 0.80

Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease. Eur Respir J (2002) 0.78

The effect of lactose on diarrhoea in the treatment of kwashiorkor. J Trop Pediatr (1980) 0.78

The interface: crucial for successful noninvasive ventilation. Eur Respir J (2004) 0.78

Prevalence of back, neck and shoulder problems in the inner city: implications for the provision of physiotherapy services in primary healthcare. Physiother Res Int (1999) 0.78

Determinants of undernutrition in rural communities of a protected area in Gabon. Public Health Nutr (2008) 0.78

Modelling the effect of venous disease on quality of life. Br J Surg (2011) 0.78

Maximal relaxation rate of inspiratory muscle can be effort-dependent and reflect the activation of fast-twitch fibers. Am Rev Respir Dis (1991) 0.77

Geriatric day care in theory and practice. Soc Work Health Care (1977) 0.77

Effect of micronutrient fortified beverage on nutritional anaemia during pregnancy. East Afr Med J (2002) 0.77

The under use of thromboprophylaxis in older medical in-patients: a regional audit. QJM (2007) 0.77

The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting. Clin Oncol (R Coll Radiol) (2001) 0.77

Non-invasive positive pressure ventilation. J R Coll Physicians Lond (2000) 0.77

[Heart failure and central respiratory dysregulation. Cheyne-Stokes respiration during sleep in advanced left heart failure]. Pneumologie (2001) 0.77

The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. Eur J Clin Nutr (2007) 0.77

Pulmonary infiltrates in the immunocompromised: diagnosis and management. Thorax (2002) 0.76

Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation. Int J Obes Relat Metab Disord (1992) 0.76

Non-invasive ventilation in acute exacerbations of COPD. QJM (1998) 0.76

Non-invasive ventilation in acute exacerbations of COPD: what happens after hospital discharge? Thorax (2004) 0.76

Are intra-articular injections of Hylan G-F 20 efficacious in painful osteoarthritis of the knee? A systematic review & meta-analysis. Int J Clin Pract (2014) 0.76

The role of non-invasive ventilation in the emergency department. Emerg Med J (2001) 0.75

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: "Don't think twice, it's alright!". Am J Respir Crit Care Med (2012) 0.75

Sleep disordered breathing following stroke. Monaldi Arch Chest Dis (2005) 0.75

The practice of growth monitoring. Lancet (1992) 0.75

The influence of supernumerary embryos on the clinical outcome of IVF cycles. J Assist Reprod Genet (2000) 0.75

Respiratory intensive care in Europe: lessons for the UK. Thorax (1998) 0.75

Noninvasive ventilation in chronic obstructive pulmonary disease. N Engl J Med (1995) 0.75

A report on the role of the general practitioner in relation to community health centres. Med J Aust (1972) 0.75

Role of intracellular symbionts in the fatbody of cockroaches: influence of hemolymph proteins. Experientia (1971) 0.75

A satellite unit. Hospitals (1970) 0.75

Effects of incremental levels of continuous positive airway pressure on cerebral blood flow velocity in healthy adult humans. Clin Sci (Lond) (2003) 0.75

Teaching health centres. Med J Aust (1972) 0.75

Improving the care for patients with acute severe respiratory disease. Thorax (2003) 0.75

Management and breeding of Aotus trivirgatus. Lab Anim Sci (1976) 0.75

The determination of bacterial motility. Med Lab Technol (1972) 0.75

Development and validation of a rapid analytical method to quantify naled residue. J Am Mosq Control Assoc (2001) 0.75

Pulmonary medicine and (adult) critical care medicine in Europe. Eur Respir J (2002) 0.75

. . . At Baptist Memorial Hospital patient concern is everyone's concern. Times (1979) 0.75

Teaching health centres. Med J Aust (1972) 0.75

Pharmacy relocation cuts costs, increases revenues. Hospitals (1985) 0.75